Sanofi Ventures, Wellington Partners, Adjuvant Capital and Industrifonden have joined existing investors in a €47.4m series-B funding for Denmark-based biotech startup MinervaX.
Sanofi Ventures, Wellington Partners, Adjuvant Capital and Industrifonden have joined existing investors in a €47.4m series-B funding for Denmark-based biotech startup MinervaX.